Marcus Q. Bernardini Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center University Health Network Biography Publications Institution JoVE Articles Marcus Q. Bernardini has not added a biography. If you are Marcus Q. Bernardini and would like to personalize this page please email our Author Liaison for assistance. Publications Molecular Characterization of Gastric-type Endocervical Adenocarcinoma Using Next-generation Sequencing Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Jul, 2019 | Pubmed ID: 31308508 Use of Porphysomes to Detect Primary Tumour, Lymph Node Metastases, Intra-abdominal Metastases and As a Tool for Image-guided Lymphadenectomy: Proof of Concept in Endometrial Cancer Theranostics. 2019 | Pubmed ID: 31131064 Evaluation of Vitamin D Biosynthesis and Pathway Target Genes Reveals UGT2A1/2 and EGFR Polymorphisms Associated with Epithelial Ovarian Cancer in African American Women Cancer Medicine. May, 2019 | Pubmed ID: 31001917 N-Glycoproteomics of Patient-Derived Xenografts: A Strategy to Discover Tumor-Associated Proteins in High-Grade Serous Ovarian Cancer Cell Systems. Apr, 2019 | Pubmed ID: 30981729 Modified Panel-based Genetic Counseling for Ovarian Cancer Susceptibility: A Randomized Non-inferiority Study Gynecologic Oncology. 04, 2019 | Pubmed ID: 30638766 Novel EPC1 Gene Fusions in Endometrial Stromal Sarcoma Genes, Chromosomes & Cancer. 11, 2018 | Pubmed ID: 30144186 Regulatory T Cells in Ovarian Cancer Are Characterized by a Highly Activated Phenotype Distinct from That in Melanoma Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2018 | Pubmed ID: 30065096 Evolution of Genetic Assessment for BRCA-associated Gynaecologic Malignancies: a Canadian Multisociety Roadmap Journal of Medical Genetics. Sep, 2018 | Pubmed ID: 30042185 Unraveling Endometriosis-associated Ovarian Carcinomas Using Integrative Proteomics F1000Research. 2018 | Pubmed ID: 29721309 A Genomically Characterized Collection of High-Grade Serous Ovarian Cancer Xenografts for Preclinical Testing The American Journal of Pathology. 05, 2018 | Pubmed ID: 29458007 The Prognostic Value of Perioperative, Pre-systemic Therapy CA125 Levels in Patients with High-grade Serous Ovarian Cancer International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. Feb, 2018 | Pubmed ID: 29095487 Implementing a Cervical Sentinel Lymph Node Biopsy Program: Quality Improvement in Gynaecologic Oncology Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique Et Gynecologie Du Canada : JOGC. Aug, 2017 | Pubmed ID: 28729099 A Multicentre Retrospective Review of Clinical Characteristics of Uterine Sarcoma Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique Et Gynecologie Du Canada : JOGC. Aug, 2017 | Pubmed ID: 28729098 Identification of 12 New Susceptibility Loci for Different Histotypes of Epithelial Ovarian Cancer Nature Genetics. May, 2017 | Pubmed ID: 28346442 A Distinct Innate Lymphoid Cell Population Regulates Tumor-associated T Cells Nature Medicine. Mar, 2017 | Pubmed ID: 28165478 Comparison of Three Surgical Approaches for Staging Lymphadenectomy in High-risk Endometrial Cancer International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics. Mar, 2017 | Pubmed ID: 28078775 Uterine Clear Cell Carcinoma: Does Adjuvant Chemotherapy Improve Outcomes? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 01, 2017 | Pubmed ID: 27668398 Validation of a Novel Biomarker Panel for the Detection of Ovarian Cancer Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology. 09, 2016 | Pubmed ID: 27448593 The Optimal Time for Surgery in Women with Serous Ovarian Cancer Canadian Journal of Surgery. Journal Canadien De Chirurgie. Aug, 2016 | Pubmed ID: 27240134 Baseline Laparoscopic Skill May Predict Baseline Robotic Skill and Early Robotic Surgery Learning Curve Journal of Endourology. 05, 2016 | Pubmed ID: 26915663 Treatment Related Outcomes in High-risk Endometrial Carcinoma: Canadian High Risk Endometrial Cancer Consortium (CHREC) Gynecologic Oncology. Apr, 2016 | Pubmed ID: 26854651 Canadian High Risk Endometrial Cancer (CHREC) Consortium: Analyzing the Clinical Behavior of High Risk Endometrial Cancers Gynecologic Oncology. Nov, 2015 | Pubmed ID: 26352641 Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women with Ovarian Cancer: Does Histotype and Stage Matter? International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Jun, 2015 | Pubmed ID: 25855958 Performance Characteristics of a Brief Family History Questionnaire to Screen for Lynch Syndrome in Women with Newly Diagnosed Endometrial Cancer Gynecologic Oncology. Feb, 2015 | Pubmed ID: 25529831 The Role of KIF14 in Patient-derived Primary Cultures of High-grade Serous Ovarian Cancer Cells Journal of Ovarian Research. 2014 | Pubmed ID: 25528264 Performance Characteristics of Screening Strategies for Lynch Syndrome in Unselected Women with Newly Diagnosed Endometrial Cancer Who Have Undergone Universal Germline Mutation Testing Cancer. Dec, 2014 | Pubmed ID: 25081409 Molecular Profiling and Clinical Outcome of High-grade Serous Ovarian Cancer Presenting with Low- Versus High-volume Ascites BioMed Research International. 2014 | Pubmed ID: 24982872 Deciphering the Peptidome of Urine from Ovarian Cancer Patients and Healthy Controls Clinical Proteomics. 2014 | Pubmed ID: 24982608 ARID1A Loss Correlates with Mismatch Repair Deficiency and Intact P53 Expression in High-grade Endometrial Carcinomas Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Feb, 2014 | Pubmed ID: 23887303 A Triage Assessment Strategy for the Management of Women with Endometrial Cancer Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstetrique Et Gynecologie Du Canada : JOGC. Apr, 2013 | Pubmed ID: 23660043 Kinesin Family Member 14: an Independent Prognostic Marker and Potential Therapeutic Target for Ovarian Cancer International Journal of Cancer. Journal International Du Cancer. Apr, 2012 | Pubmed ID: 21618518 Identification and Quantification of Peritoneal Metastases in Patients with Ovarian Cancer with Multidetector Computed Tomography: Correlation with Surgery and Surgical Outcome International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. Nov, 2011 | Pubmed ID: 21997169 Phenotypic Heterogeneity and Instability of Human Ovarian Tumor-initiating Cells Proceedings of the National Academy of Sciences of the United States of America. Apr, 2011 | Pubmed ID: 21451132 Evaluation of Two Management Strategies for Preoperative Grade 1 Endometrial Cancer Obstetrics and Gynecology. Jul, 2009 | Pubmed ID: 19546752 Issues Surrounding Lymphadenectomy in the Management of Endometrial Cancer Journal of Surgical Oncology. Mar, 2009 | Pubmed ID: 19072933 Een Orthothematisch endometriumkanker model met Retroperitoneale lymfadenopathie gemaakt van in vivo gepropageerd en gekweekte VX2 cellen Lauren Philp1,2, Harley Chan3, Marjan Rouzbahman4, Ariana Rostami5, Lili Ding6, Scott V. Bratman5,6, Margarete K. Akens5,7,8, Jonathan C. Irish7,9,11, Marcus Q. Bernardini10, Gang Zheng5,11 1Institute of Medical Science, University of Toronto, 2Department of Obstetrics and Gynecology, University of Toronto, 3Guided Therapeutics Laboratory, TECHNA Institute, University Health Network, 4Department of Pathology, Princess Margaret Cancer Center, University Health Network, 5Department of Medical Biophysics, University of Toronto, 6Princess Margaret Cancer Center, University Health Network, 7Techna Institute, University Health Network, 8Department of Surgery, University of Toronto, 9Department of Otolaryngology, Head and Neck Surgery, University of Toronto, 10Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center, University Health Network, 11Princess Margaret Cancer Center, University Health Network JoVE 59340 Cancer Research
Een Orthothematisch endometriumkanker model met Retroperitoneale lymfadenopathie gemaakt van in vivo gepropageerd en gekweekte VX2 cellen Lauren Philp1,2, Harley Chan3, Marjan Rouzbahman4, Ariana Rostami5, Lili Ding6, Scott V. Bratman5,6, Margarete K. Akens5,7,8, Jonathan C. Irish7,9,11, Marcus Q. Bernardini10, Gang Zheng5,11 1Institute of Medical Science, University of Toronto, 2Department of Obstetrics and Gynecology, University of Toronto, 3Guided Therapeutics Laboratory, TECHNA Institute, University Health Network, 4Department of Pathology, Princess Margaret Cancer Center, University Health Network, 5Department of Medical Biophysics, University of Toronto, 6Princess Margaret Cancer Center, University Health Network, 7Techna Institute, University Health Network, 8Department of Surgery, University of Toronto, 9Department of Otolaryngology, Head and Neck Surgery, University of Toronto, 10Division of Gynecologic Oncology, University of Toronto /Princess Margaret Cancer Center, University Health Network, 11Princess Margaret Cancer Center, University Health Network JoVE 59340 Cancer Research